X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (280) 280
Book Review (67) 67
Publication (33) 33
Conference Proceeding (28) 28
Book Chapter (7) 7
Web Resource (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (117) 117
index medicus (108) 108
humans (105) 105
cancer (52) 52
chemotherapy (35) 35
nsclc (35) 35
lung cancer (34) 34
carcinoma, non-small-cell lung - drug therapy (31) 31
lung neoplasms - drug therapy (31) 31
carcinoma, non-small-cell lung - genetics (30) 30
animals (29) 29
lung neoplasms - genetics (29) 29
antineoplastic agents - therapeutic use (27) 27
1st-line treatment (26) 26
female (26) 26
non-small cell lung cancer (26) 26
open-label (26) 26
human medicine (25) 25
male (24) 24
mutation (24) 24
immunotherapy (23) 23
tumors (23) 23
cell lung-cancer (22) 22
care and treatment (21) 21
respiratory system (21) 21
review (21) 21
lung neoplasms - pathology (20) 20
pharmacology & pharmacy (20) 20
hematology, oncology and palliative medicine (19) 19
molecular targeted therapy (19) 19
settore med/06 - oncologia medica (19) 19
biomarkers (18) 18
carcinoma, non-small-cell lung - pathology (18) 18
expression (18) 18
middle aged (18) 18
lung cancer, non-small cell (16) 16
medicine, research & experimental (16) 16
prognosis (16) 16
cancer therapies (15) 15
exosomes (15) 15
gefitinib (15) 15
aged (14) 14
liquid biopsy (14) 14
metastasis (14) 14
protein kinase inhibitors - therapeutic use (14) 14
research (14) 14
cell biology (13) 13
egfr (13) 13
erlotinib (13) 13
genetic aspects (13) 13
proteins (13) 13
targeted therapy (13) 13
tyrosine kinase inhibitors (13) 13
antineoplastic agents - pharmacology (12) 12
cell line, tumor (12) 12
hematology (12) 12
medicine & public health (12) 12
pathology (12) 12
resistance (12) 12
treatment outcome (12) 12
adult (11) 11
biotechnology & applied microbiology (11) 11
diagnosis (11) 11
epidermal growth factor (11) 11
growth-factor receptor (11) 11
medicine (11) 11
patients (11) 11
receptor, epidermal growth factor - genetics (11) 11
survival (11) 11
therapy (11) 11
acquired-resistance (10) 10
adenocarcinoma (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
apoptosis (10) 10
clinical trials (10) 10
double-blind (10) 10
microrna (10) 10
phase-iii (10) 10
research paper (10) 10
analysis (9) 9
antibodies, monoclonal - therapeutic use (9) 9
antineoplastic agents - adverse effects (9) 9
colorectal cancer (9) 9
colorectal-cancer (9) 9
medical research (9) 9
micrornas (9) 9
neoplasms. tumors. oncology. including cancer and carcinogens (9) 9
receptor, epidermal growth factor - antagonists & inhibitors (9) 9
antineoplastic agents (8) 8
biology (8) 8
breast cancer (8) 8
breast-cancer (8) 8
drug therapy (8) 8
gene expression regulation, neoplastic (8) 8
health aspects (8) 8
micrornas - genetics (8) 8
neoplasms (8) 8
phase-ii trial (8) 8
randomized phase-ii (8) 8
respiratory tract diseases (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, Current Clinical Pathology, ISBN 9783319556611
This text is designed to provide readers with a useful and comprehensive resource and state-of-the-art overview about the new, growing and fast-expanding field... 
Medicine | Pathology | Oncology
Web Resource
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2016, Volume 11, Issue 10, pp. 1609 - 1611
Journal Article
2015, Current Clinical Pathology, ISBN 9781493920471
This volume provides readers a comprehensive and state-of-the-art overview about the range of applications of targeted therapies for solid tumors. The sections... 
Medicine | Pathology | Oncology
Web Resource
Nature nanotechnology, ISSN 1748-3387, 01/2018, Volume 13, Issue 1, pp. 6 - 7
Nanoparticles loaded with paclitaxel and nintedanib induce synthetic lethality in endometrial cancer cells. 
Nanoparticles | Humans | Endometrial Neoplasms | Lethality | Endometrium | Paclitaxel | Cancer | Index Medicus
Journal Article
Laboratory Investigation, ISSN 0023-6837, 11/2017, Volume 97, Issue 11, pp. 1268 - 1270
Neurotrophic tyrosine kinase genes encode for the Trk-family proteins TrkA, TrkB, and TrkC, which have an important role in the development of the nervous... 
MEDICINE, RESEARCH & EXPERIMENTAL | ADVANCED SOLID TUMORS | ENTRECTINIB | ORAL PAN-TRK | RELEVANT MOLECULAR ALTERATIONS | PATHOLOGY | ALK INHIBITOR | ROS1 | EXPRESSION | Lung Neoplasms - drug therapy | Oncogene Proteins, Fusion - metabolism | Membrane Glycoproteins - metabolism | Humans | Lung Neoplasms - metabolism | Receptor, trkA - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Receptor, trkB - genetics | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Antineoplastic Agents - adverse effects | Neoplasms, Squamous Cell - drug therapy | Receptor, trkB - antagonists & inhibitors | Lung Neoplasms - genetics | Molecular Targeted Therapy - adverse effects | Receptor, trkC - antagonists & inhibitors | Membrane Glycoproteins - genetics | Animals | Neoplasms, Squamous Cell - genetics | Receptor Protein-Tyrosine Kinases - genetics | Receptor, trkA - metabolism | Oncogene Proteins, Fusion - genetics | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Receptor, trkB - metabolism | Receptor, trkC - metabolism | Neoplasms, Squamous Cell - metabolism | Toxicity | Lung cancer | Lung | Clinical trials | Fluorescence | Nervous system | Kinases | Proteins | Fluorescence in situ hybridization | TrkA protein | TrkA receptors | Protein-tyrosine kinase | Tyrosine | Medical research | Squamous cell carcinoma | Invasiveness | Feasibility studies | Lung carcinoma | Patients | Brain-derived neurotrophic factor | Inhibitors | TrkB receptors | Solid tumors | Tumors | Cancer | Plastic foam | Index Medicus
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 592 - 594
Journal Article
by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 10, pp. 958 - 967
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2015, Volume 230, Issue 6, pp. 1276 - 1289
The sesquiterpene lactone Parthenolide (PN) exerted a cytotoxic effect on MDA-MB231 cells, a triple-negative breast cancer (TNBC) cell line, but its... 
APOPTOSIS | PHYSIOLOGY | THERAPY | DNA METHYLATION | SUBEROYLANILIDE HYDROXAMIC ACID | LEUKEMIA-CELLS | AUTOPHAGY | SESQUITERPENE LACTONE PARTHENOLIDE | HISTONE DEACETYLASE INHIBITORS | NF-KAPPA-B | TUMOR-GROWTH | CELL BIOLOGY | Histones | Breast cancer | Cytotoxicity | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 2317 - 2317
Journal Article
ecancermedicalscience, ISSN 1754-6605, 12/2016, Volume 10, p. 708
Liver cancer is the second leading cause of cancer death worldwide, with hepatocellular carcinoma (HCC) being the most common type of primary malignant liver... 
Genetics | Brothers | Relatives | Hepatocarcinoma (HCC) | Twins | Hypertension | Alcohol | Infections | Family medical history | Patients | Thrombosis | Cancer therapies | Abdomen | Liver cancer | Hepatitis | Ultrasonic imaging | Illnesses | Biopsy | Diabetes | Drug dosages | Tumors | twins | genetics | relatives | hepatocarcinoma (HCC) | brothers | Case Report
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2017, Volume 7, Issue 1, pp. 3170 - 14
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease... 
CELL LUNG-CANCER | TYROSINE KINASE INHIBITORS | BREAST-CANCER | SURVIVAL | GROWTH-FACTOR RECEPTOR | INVASION | BONE METASTASES | PREDICTORS | MULTIDISCIPLINARY SCIENCES | MYELOGENOUS LEUKEMIA-CELLS | EXPRESSION | RNA, Small Interfering - genetics | RANK Ligand - metabolism | Coculture Techniques | Humans | Lung Neoplasms - metabolism | ErbB Receptors - genetics | Gene Expression Regulation, Neoplastic | Bone Neoplasms - secondary | Exosomes - pathology | Lung Neoplasms - pathology | Bone Neoplasms - metabolism | Biological Transport | Amphiregulin - metabolism | Bone Neoplasms - genetics | Cell Differentiation | Amphiregulin - genetics | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Osteoclasts - pathology | ErbB Receptors - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Osteoclasts - metabolism | RANK Ligand - genetics | Animals | Cell Line, Tumor | RAW 264.7 Cells | Exosomes - chemistry | Mice | Primary Cell Culture | RNA, Small Interfering - metabolism | Intercellular signalling | Epidermal growth factor receptors | Proteolytic enzymes | Non-small cell lung carcinoma | Metastasis | Tumor cell lines | Amphiregulin | Osteolysis | Cell interactions | Exosomes | Osteoblasts | Metastases | Osteoclastogenesis | Epidermal growth factor | Proteolysis | Osteoclasts | Colon | TRANCE protein | Cancer | Index Medicus
Journal Article
Cancer Letters, ISSN 0304-3835, 2016, Volume 375, Issue 2, pp. 313 - 322
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 1 - 10
Fluid-earthquake interplay, as evidenced by aftershock distributions or earthquake-induced effects on near-surface aquifers, has suggested that earthquakes... 
SYSTEM | HIMALAYAN | DISTANT EARTHQUAKES | PERMEABILITY | TEMPERATURE | MULTIDISCIPLINARY SCIENCES | SEQUENCE | CALC-SILICATE ROCKS | CARBON-DIOXIDE | GORKHA EARTHQUAKE | FLOW | Hydrothermal systems | Deformation | Seismic activity | Earthquake engineering | Carbon dioxide | Permeability | Seismic phenomena | Aquifers | Emissions | Earth crust | Earthquakes | Seismic effects | Carbon monoxide | Seismic response
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 04/2018, Volume 10, Issue S9, pp. S1076 - S1080
Journal Article
Journal Article